Translational Medicine

Medicine & Life Sciences

1. 4-1BB Ligand 10%
2. Abatacept 8%
3. Age of Onset 6%
4. Allergy and Immunology 6%
5. Anti-Idiotypic Antibodies 6%
6. Antibodies 15%
7. Antigens 8%
8. Arthralgia 8%
9. Autoantibodies 41%
10. Autoimmune Diseases 100%
11. Autoimmune Hepatitis 7%
12. Autoimmunity 60%
13. B-Lymphocytes 6%
14. Biliary Liver Cirrhosis 10%
15. Biomarkers 10%
16. Blood Platelets 9%
17. Catalytic Domain 5%
18. Central Tolerance 5%
19. Chromatin 6%
20. Chronic Inflammatory Demyelinating Polyradiculoneuropathy 8%
21. Cigarette Smoking 6%
22. Clopidogrel 14%
23. Cluster Analysis 9%
24. Coffee 10%
25. Colombia 30%
26. Confidence Intervals 7%
27. Coronavirus 58%
28. Cytokines 15%
29. Ebola Hemorrhagic Fever 8%
30. Ebolavirus 8%
31. Ecology 11%
32. Epigenomics 5%
33. Epitopes 8%
34. ETP-46321 15%
35. Experimental Arthritis 7%
36. Extracellular Traps 9%
37. Fibrosis 6%
38. Focus Groups 5%
39. Genetic Background 6%
40. Genetic Predisposition to Disease 5%
41. glucose-regulated proteins 8%
42. High-Throughput Nucleotide Sequencing 11%
43. Histones 5%
44. HLA Antigens 6%
45. Hyperprolactinemia 7%
46. IC 87114 6%
47. Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome 11%
48. Immune System 11%
49. Immune Tolerance 7%
50. Immunoglobulin G 9%
51. Inbred NOD Mouse 5%
52. Incidence 5%
53. Infections 10%
54. Inflammation 5%
55. Interleukin-17 6%
56. Interleukin-6 9%
57. Latin America 22%
58. Liver Cirrhosis 5%
59. Lymphocyte Activation 6%
60. Meta-Analysis 23%
61. Metabolomics 9%
62. Minor Salivary Glands 9%
63. Molecular Mimicry 14%
64. Mortality 10%
65. Neural Conduction 6%
66. Pandemics 19%
67. Papillomavirus Infections 6%
68. Patient Reported Outcome Measures 6%
69. Pharmacogenomic Testing 16%
70. Phosphatidylinositol 3-Kinases 12%
71. Phosphoinositide-3 Kinase Inhibitors 8%
72. Phospholipids 5%
73. Polymyalgia Rheumatica 8%
74. Population 11%
75. Precision Medicine 6%
76. Primary Immunodeficiency Diseases 8%
77. Prolactin 6%
78. Proteins 5%
79. Randomized Controlled Trials 8%
80. Regulatory T-Lymphocytes 5%
81. Rheumatic Diseases 14%
82. Rheumatoid Arthritis 42%
83. Rheumatoid Factor 8%
84. SARS Virus 58%
85. Severe Acute Respiratory Syndrome 11%
86. SS-A antibodies 10%
87. Systematic Reviews 25%
88. Systemic Lupus Erythematosus 22%
89. Systemic Scleroderma 18%
90. Systems Biology 7%
91. T-Lymphocytes 28%
92. Therapeutics 12%
93. Thyroid Diseases 22%
94. Thyroid Gland 6%
95. Type 1 Diabetes Mellitus 12%
96. Vaccination 13%
97. Vaccines 13%
98. Viral Envelope Proteins 8%
99. Zika Virus 9%
100. Zika Virus Infection 10%